Cite
In vitro antifungal susceptibilities and amplified fragment length polymorphism genotyping of a worldwide collection of 350 clinical, veterinary, and environmental Cryptococcus gattii isolates.
MLA
Hagen, Ferry, et al. “In Vitro Antifungal Susceptibilities and Amplified Fragment Length Polymorphism Genotyping of a Worldwide Collection of 350 Clinical, Veterinary, and Environmental Cryptococcus Gattii Isolates.” Antimicrobial Agents and Chemotherapy, vol. 54, no. 12, Dec. 2010, pp. 5139–45. EBSCOhost, https://doi.org/10.1128/AAC.00746-10.
APA
Hagen, F., Illnait-Zaragozi, M.-T., Bartlett, K. H., Swinne, D., Geertsen, E., Klaassen, C. H. W., Boekhout, T., & Meis, J. F. (2010). In vitro antifungal susceptibilities and amplified fragment length polymorphism genotyping of a worldwide collection of 350 clinical, veterinary, and environmental Cryptococcus gattii isolates. Antimicrobial Agents and Chemotherapy, 54(12), 5139–5145. https://doi.org/10.1128/AAC.00746-10
Chicago
Hagen, Ferry, Maria-Teresa Illnait-Zaragozi, Karen H Bartlett, Daniëlle Swinne, Erik Geertsen, Corné H W Klaassen, Teun Boekhout, and Jacques F Meis. 2010. “In Vitro Antifungal Susceptibilities and Amplified Fragment Length Polymorphism Genotyping of a Worldwide Collection of 350 Clinical, Veterinary, and Environmental Cryptococcus Gattii Isolates.” Antimicrobial Agents and Chemotherapy 54 (12): 5139–45. doi:10.1128/AAC.00746-10.